Clinical trial
Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application. Clinical Investigation: NS-BOOSST
NCT07108088 is registered in ClinicalTrials.gov with ÖSSUR France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application. Clinical Investigation: NS-BOOSST
- Lead sponsor
- ÖSSUR France
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 13, 2025
- Completion date
- December 31, 2026
- Enrollment
- 34 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral palsy, multiple sclerosis, neuromuscular deficits, stroke